abstracts: https://doi.org/10.1182/blood-2018-120737
This data as json
| doi | article_title | article_date | session_type | topics | author_names | author_affiliations | first_author_latitude | first_author_longitude |
|---|---|---|---|---|---|---|---|---|
| https://doi.org/10.1182/blood-2018-120737 | Phase 3 Randomized Study of Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Ineligible for Transplant (MAIA) | November 29, 2018 | Late-Breaking Abstracts Session | ["daratumumab", "dexamethasone", "lenalidomide", "multiple myeloma", "transplantation", "disease progression", "bortezomib", "electrocorticogram", "follow-up", "surrogate endpoints"] | ["Thierry Facon", "Shaji K. Kumar, MD", "Torben Plesner, MD DSc", "Robert Z. Orlowski, MD PhD", "Philippe Moreau", "Nizar Bahlis, MD", "Supratik Basu, MBBS, MD FRCP, FRCPath", "Hareth Nahi, MD PhD", "Cyrille Hulin, MD", "Hang Quach, MDFRACP,FRCPA,MBBS", "Hartmut Goldschmidt, MD", "Michael O'Dwyer", "Aurore Perrot", "Christopher P. Venner, MD FRCPC", "Katja Weisel, MD", "Joseph R. Mace", "Tahamtan Ahmadi", "Christopher Chiu, PhD", "Jianping Wang", "Rian Van Rampelbergh", "Clarissa M. Uhlar", "Rachel Kobos, MD", "Ming Qi, MD PhD", "Saad Z. Usmani, MD"] | [["Service des Maladies du Sang, Hôpital Claude Huriez, Lille, France "], ["Department of Hematology, Mayo Clinic, Rochester, MN "], ["Vejle Hospital and University of Southern Denmark, Vejle, Denmark"], ["Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX "], ["Hematology, University Hospital Hôtel-Dieu, Nantes, France "], ["University of Calgary, Arnie Charbonneau Cancer Institute, Calgary, Canada "], ["Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, United Kingdom "], ["Karolinska Institute, Department of Medicine, Division of Hematology, Karolinska University Hospital at Huddinge, Stockholm, Sweden "], ["Department of Hematology, Hospital Haut Leveque, University Hospital, Pessac, France "], ["St. Vincent's Hospital, University of Melbourne, Melbourne, Australia "], ["University Hospital Heidelberg and National Center of Tumor Diseases (NCT), Heidelberg, Germany "], ["Dept. of Medicine/Haematology, NUI, Galway, Ireland "], ["Hematology Department, University Hospital, Vandoeuvre Les Nancy, France "], ["Division of Medical Oncology University of Alberta, Edmonton, Canada "], ["Universitaetsklinikum Tuebingen der Eberhard-Karls-Universitaet, Abteilung fuer Innere Medizin II, Tuebingen, Germany "], ["Florida Cancer Specialists & Research Institute, St. Petersburg, FL "], ["Genmab US, Inc., Princeton, NJ "], ["Janssen Research & Development, LLC, Spring House, PA "], ["Janssen Research & Development, LLC, Raritan, NJ "], ["Janssen Research & Development, Beerse, Belgium "], ["Janssen Research & Development, LLC, Spring House, PA "], ["Janssen Research & Development, LLC, Raritan, NJ "], ["Janssen Research & Development, LLC, Spring House, PA "], ["Levine Cancer Institute/Atrium Health, Charlotte, NC"]] | 50.611495999999995 | 3.036616 |